Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy.
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D003587:Cytomegalovirus / Q000302:isolation & purification; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced / Q000151:congenital*; D007231:Infant, Newborn; D008213:Lymphocyte Activation; D008231:Lymphopenia / Q000139:chemically induced / Q000151:congenital; D008297:Male; D008431:Maternal-Fetal Exchange; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011859:Radiography; D013950:Thymus Gland / Q000000981:diagnostic imaging; D014556:Urine / Q000382:microbiology
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D001379:Azathioprine; D011241:Prednisone